Gofen & Glossberg LLC IL boosted its holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 41.5% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 7,838 shares of the medical instruments supplier’s stock after purchasing an additional 2,297 shares during the quarter. Gofen & Glossberg LLC IL’s holdings in DENTSPLY SIRONA were worth $469,000 as of its most recent SEC filing.
Other hedge funds have also bought and sold shares of the company. Veritas Asset Management LLP boosted its position in shares of DENTSPLY SIRONA by 2.6% during the 2nd quarter. Veritas Asset Management LLP now owns 6,201,155 shares of the medical instruments supplier’s stock valued at $402,083,000 after acquiring an additional 157,616 shares during the last quarter. Bronfman E.L. Rothschild L.P. boosted its position in shares of DENTSPLY SIRONA by 78.7% during the 2nd quarter. Bronfman E.L. Rothschild L.P. now owns 11,886 shares of the medical instruments supplier’s stock valued at $771,000 after acquiring an additional 5,236 shares during the last quarter. Royce & Associates LP boosted its position in shares of DENTSPLY SIRONA by 23.4% during the 2nd quarter. Royce & Associates LP now owns 126,650 shares of the medical instruments supplier’s stock valued at $8,212,000 after acquiring an additional 24,000 shares during the last quarter. Delta Lloyd Asset Management N.V. bought a new position in shares of DENTSPLY SIRONA during the 2nd quarter valued at approximately $15,624,000. Finally, Grandfield & Dodd LLC boosted its position in shares of DENTSPLY SIRONA by 1.8% during the 3rd quarter. Grandfield & Dodd LLC now owns 236,109 shares of the medical instruments supplier’s stock valued at $14,122,000 after acquiring an additional 4,140 shares during the last quarter. Institutional investors and hedge funds own 96.58% of the company’s stock.
Shares of DENTSPLY SIRONA Inc. (XRAY) opened at $65.65 on Friday. DENTSPLY SIRONA Inc. has a twelve month low of $52.53 and a twelve month high of $68.98. The firm has a market capitalization of $15,172.85, a price-to-earnings ratio of 26.32, a P/E/G ratio of 2.62 and a beta of 1.31. The company has a current ratio of 2.32, a quick ratio of 1.59 and a debt-to-equity ratio of 0.21.
DENTSPLY SIRONA (NASDAQ:XRAY) last released its quarterly earnings results on Friday, November 3rd. The medical instruments supplier reported $0.70 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $0.66 by $0.04. DENTSPLY SIRONA had a positive return on equity of 7.56% and a negative net margin of 20.33%. The company had revenue of $1.01 billion for the quarter, compared to analyst estimates of $978.99 million. During the same quarter in the prior year, the firm posted $0.66 EPS. DENTSPLY SIRONA’s quarterly revenue was up 5.8% compared to the same quarter last year. equities analysts forecast that DENTSPLY SIRONA Inc. will post 2.65 earnings per share for the current fiscal year.
The business also recently declared a quarterly dividend, which will be paid on Friday, January 12th. Investors of record on Friday, December 29th will be issued a dividend of $0.0875 per share. The ex-dividend date of this dividend is Thursday, December 28th. This represents a $0.35 annualized dividend and a yield of 0.53%. DENTSPLY SIRONA’s payout ratio is presently -10.09%.
In related news, CFO Nicholas W. Alexos purchased 50,000 shares of the firm’s stock in a transaction that occurred on Monday, November 13th. The shares were bought at an average price of $65.85 per share, for a total transaction of $3,292,500.00. The acquisition was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director Francis J. Lunger sold 8,900 shares of the stock in a transaction on Monday, November 13th. The shares were sold at an average price of $65.90, for a total value of $586,510.00. The disclosure for this sale can be found here. Corporate insiders own 1.99% of the company’s stock.
A number of research firms have recently commented on XRAY. J P Morgan Chase & Co upgraded DENTSPLY SIRONA from a “neutral” rating to an “overweight” rating and set a $75.00 target price for the company in a research report on Wednesday. Deutsche Bank began coverage on DENTSPLY SIRONA in a research report on Friday, December 8th. They set a “buy” rating and a $81.00 target price for the company. HC Wainwright reiterated a “hold” rating and set a $68.00 target price on shares of DENTSPLY SIRONA in a research report on Thursday, December 7th. BidaskClub downgraded DENTSPLY SIRONA from a “strong-buy” rating to a “buy” rating in a research report on Saturday, December 2nd. Finally, Stephens began coverage on DENTSPLY SIRONA in a research report on Tuesday, November 28th. They set an “overweight” rating and a $75.00 target price for the company. Two research analysts have rated the stock with a sell rating, three have issued a hold rating and ten have given a buy rating to the company’s stock. DENTSPLY SIRONA currently has a consensus rating of “Buy” and an average price target of $69.31.
ILLEGAL ACTIVITY WARNING: This piece was reported by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this piece on another website, it was illegally stolen and republished in violation of United States and international trademark & copyright laws. The legal version of this piece can be viewed at https://ledgergazette.com/2017/12/15/dentsply-sirona-inc-xray-holdings-lifted-by-gofen-glossberg-llc-il.html.
About DENTSPLY SIRONA
DENTSPLY SIRONA Inc is a manufacturer of professional dental products and technologies. The Company develops, manufactures, and markets solutions offering, including dental and oral health products, as well as other consumable medical devices. It operates through two segments: Dental and Healthcare Consumables, and Technologies.
Want to see what other hedge funds are holding XRAY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DENTSPLY SIRONA Inc. (NASDAQ:XRAY).
Receive News & Ratings for DENTSPLY SIRONA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DENTSPLY SIRONA and related companies with MarketBeat.com's FREE daily email newsletter.